Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$3.8M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 7 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 36 most recent Form 4 transactions.
| Jul 10 | NBIX | Neurocrine Biosciences INC | MEXER◷◆ | 4,367 | — | — | — | Open the original filing on SEC.gov |
| Jul 10 | NBIX | Neurocrine Biosciences INC | SSELL◷ | 4,367 | $181.02 | $790.5K | -21.2% | Open the original filing on SEC.gov |
| Jul 10 | NBIX | Neurocrine Biosciences INC | MEXER◷ | 4,367 | $106.02 | $463K | +26.9% | Open the original filing on SEC.gov |
| Jul 9 | NBIX | Neurocrine Biosciences INC | MEXER◷◆ | 8,433 | — | — | — | Open the original filing on SEC.gov |
| Jul 9 | NBIX | Neurocrine Biosciences INC | SSELL◷ | 8,433 | $178.72 | $1.5M | -34.2% | Open the original filing on SEC.gov |
| Jul 9 | NBIX | Neurocrine Biosciences INC | MEXER◷ | 8,433 | $103.52 | $873K | +52.0% | Open the original filing on SEC.gov |
| Jul 8 | NBIX | Neurocrine Biosciences INC | MEXER◷◆ | 2,737 | — | — | — | Open the original filing on SEC.gov |
| Jul 8 | NBIX | Neurocrine Biosciences INC | SSELL◷ | 2,737 | $178.54 | $488.7K | -14.4% | Open the original filing on SEC.gov |
| Jul 8 | NBIX | Neurocrine Biosciences INC | MEXER◷ | 2,737 | $103.52 | $283.3K | +16.9% | Open the original filing on SEC.gov |
| Jul 7 | NBIX | Neurocrine Biosciences INC | MEXER◷◆ | 3,401 | — | — | — | Open the original filing on SEC.gov |
| Jul 7 | NBIX | Neurocrine Biosciences INC | SSELL◷ | 3,401 | $178.57 | $607.3K | -17.3% | Open the original filing on SEC.gov |
| Jul 7 | NBIX | Neurocrine Biosciences INC | MEXER◷ | 3,401 | $103.52 | $352.1K | +21.0% | Open the original filing on SEC.gov |
| May 29 | NBIX | Neurocrine Biosciences INC | MEXER◷◆ | 2,261 | — | — | — | Open the original filing on SEC.gov |
| May 29 | NBIX | Neurocrine Biosciences INC | SSELL◷ | 2,261 | $156.71 | $354.3K | -12.2% | Open the original filing on SEC.gov |
| May 29 | NBIX | Neurocrine Biosciences INC | MEXER◷ | 2,261 | $79.02 | $178.7K | +13.9% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | AGRANT◆ | 5,479 | — | — | — | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | AGRANT◆ | 31,234 | — | — | — | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | MEXER◆ | 1,359 | — | — | — | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | MEXER◆ | 1,401 | — | — | — | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | FTAX | 10,755 | $124.12 | $1.3M | -39.9% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | AGRANT | 19,935 | — | — | +283.0% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | FTAX | 734 | $124.12 | $91.1K | -9.4% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | MEXER | 1,359 | — | — | +21.2% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | FTAX | 756 | $124.12 | $93.8K | -10.5% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | MEXER | 1,401 | — | — | +24.3% | Open the original filing on SEC.gov |
| Feb 12 | NBIX | Neurocrine Biosciences INC | MEXER◆ | 1,600 | — | — | — | Open the original filing on SEC.gov |
| Feb 12 | NBIX | Neurocrine Biosciences INC | FTAX | 881 | $123.10 | $108.5K | -13.2% | Open the original filing on SEC.gov |
| Feb 12 | NBIX | Neurocrine Biosciences INC | MEXER | 1,600 | — | — | +31.6% | Open the original filing on SEC.gov |
| Jan 31 | NBIX | Neurocrine Biosciences INC | MEXER◆ | 801 | — | — | — | Open the original filing on SEC.gov |
| Jan 31 | NBIX | Neurocrine Biosciences INC | FTAX | 475 | $136.06 | $64.6K | -8.6% | Open the original filing on SEC.gov |
| Jan 31 | NBIX | Neurocrine Biosciences INC | MEXER | 801 | — | — | +16.9% | Open the original filing on SEC.gov |
| Jul 10, 2025 | NBIX | Neurocrine Biosciences INC | MEXER◷◆ | 457 | — | — | — | Open the original filing on SEC.gov |
| Jul 10, 2025 | NBIX | Neurocrine Biosciences INC | SSELL◷ | 457 | $135.00 | $61.7K | -8.8% | Open the original filing on SEC.gov |
| Jul 10, 2025 | NBIX | Neurocrine Biosciences INC | MEXER◷ | 457 | $79.02 | $36.1K | +9.7% | Open the original filing on SEC.gov |